Philip D. Kanof

2.8k total citations · 1 hit paper
37 papers, 2.3k citations indexed

About

Philip D. Kanof is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Philip D. Kanof has authored 37 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 13 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Philip D. Kanof's work include Cholinesterase and Neurodegenerative Diseases (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Memory and Neural Mechanisms (9 papers). Philip D. Kanof is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Memory and Neural Mechanisms (9 papers). Philip D. Kanof collaborates with scholars based in United States. Philip D. Kanof's co-authors include Paul Greengard, Vahram Haroutunian, Kenneth L. Davis, Leonard Handelsman, Karen Rubinstein, Robert C. Ness, Keith L. Davis, Linda R. Hegstrand, Daniel P. Perl and Dushyant P. Purohit and has published in prestigious journals such as Nature, Journal of Biological Chemistry and American Journal of Psychiatry.

In The Last Decade

Philip D. Kanof

37 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two New Rating Scales for Opiate Withdrawal

1987 464 citations Leonard Handelsman, Robert C. Ness et al. The American Journal of Drug and Alcohol Abuse profile →

Peers

Countries citing papers authored by Philip D. Kanof

Since Specialization

Citations

This map shows the geographic impact of Philip D. Kanof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Kanof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Kanof more than expected).

Fields of papers citing papers by Philip D. Kanof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Kanof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Kanof. The network helps show where Philip D. Kanof may publish in the future.

Co-authorship network of co-authors of Philip D. Kanof

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Kanof. A scholar is included among the top collaborators of Philip D. Kanof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Kanof. Philip D. Kanof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cognitive Dysfunction and Disability in Geriatric Veterans with Self-Reported Intolerance to Environmental Chemicals 1997 ·Journal of Chronic Fatigue Syndrome ·Iris R. Bell, Michele E. Walsh, (unknown), (unknown), Gary E. Schwartz, Philip D. Kanof	8
2	Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits 1995 ·Journal of Neurochemistry ·Linda M. Bierer, Vahram Haroutunian, (unknown), Peter J. Knott, (unknown), Dushyant P. Purohit, Daniel P. Perl, James Schmeidler, Philip D. Kanof, Kenneth L. Davis	494
3	Transient Enhancement of Cholinergic Neurochemical Markers Induced by NGF in Aged F344 Rats 1995 ·Dementia and Geriatric Cognitive Disorders ·Anthony C. Santucci, Philip D. Kanof, Vahram Haroutunian	5
4	Cortical cholinergic markers in schizophrenia 1994 ·Schizophrenia Research ·Vahram Haroutunian, Michael Davidson, Philip D. Kanof, Daniel P. Perl, Peter Powchik, Miklos Losonczy, (unknown), Dushyant P. Purohit, Linda M. Bierer, Keith L. Davis	65
5	The Acute Effects of a Rapid Medical Detoxification upon Dysphoria and Other Psychopathology Experienced by Heroin Abusers 1994 ·The Journal of Nervous and Mental Disease ·(unknown), Leonard Handelsman, (unknown), (unknown), Philip D. Kanof	16
6	Induction of Memory and Cortical Cholinergic Neurochemical Recovery with Combine Fetal Transplantation and GM1 Treatments in Rats with Lesions of the NBM 1993 ·Dementia and Geriatric Cognitive Disorders ·Anthony C. Santucci, (unknown), Philip D. Kanof, Vahram Haroutunian	5
7	Cholinergic marker deficits induced by lesions of the nucleus basalis of Meynert are attenuated by nerve growth factor in young, but not in aged, F344 rats 1993 ·Brain Research ·Anthony C. Santucci, Philip D. Kanof, V. Haroutunian	13
8	Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Philip D. Kanof, Leonard Handelsman, (unknown), R. B. Ness, (unknown), Karen Rubinstein	56
9	Levels of opioid physical dependence in heroin addicts 1991 ·Drug and Alcohol Dependence ·Philip D. Kanof, (unknown), (unknown), (unknown), Thomas Horvath, Leonard Handelsman	13
10	Platelet phospholipid synthesis in Alzheimer's disease 1991 ·Neurobiology of Aging ·Philip D. Kanof, (unknown), (unknown), Michael Davidson, Linda M. Bierer, (unknown)	2
11	Effects of indomethacin on plasma homovanillic acid concentration in normal subjects: a study of prostaglandin-dopamine interactions 1991 ·Psychopharmacology ·René S. Kahn, Michael Davidson, Philip D. Kanof, (unknown), (unknown), Kenneth L. Davis	5
12	Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats 1990 ·Brain Research ·Vahram Haroutunian, Philip D. Kanof, (unknown), Kenneth L. Davis	74
13	Frontal cortex as the site of action of physostigmine in nbM-lesioned rats 1990 ·Physiology & Behavior ·Vahram Haroutunian, (unknown), Philip D. Kanof	15
14	Infusion of NMDA into the nucleus basalis of Meynert, frontal cortex or lateral ventricle in rats: effect on memory and cholinergic brain neurochemistry 1989 ·Pharmacology Biochemistry and Behavior ·Anthony C. Santucci, Philip D. Kanof, Vahram Haroutunian	7
15	Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factor 1989 ·Brain Research ·Vahram Haroutunian, Philip D. Kanof, Keith L. Davis	49
16	Interactions of forebrain cholinergic and somatostinergic systems in the rat 1989 ·Brain Research ·Vahram Haroutunian, Philip D. Kanof, Keith L. Davis	19
17	Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats 1989 ·Psychopharmacology ·Anthony C. Santucci, Philip D. Kanof, Vahram Haroutunian	56
18	Platelet alpha2-adrenergic receptor function in psychiatric disorders 1988 ·Psychiatry Research ·Philip D. Kanof, Celeste A. Johns, Michael Davidson, Larry J. Siever, Emil F. Coccaro, Kenneth L. Davis	13
19	Two New Rating Scales for Opiate Withdrawal breakdown → 1987 ·The American Journal of Drug and Alcohol Abuse ·Leonard Handelsman, (unknown), (unknown), Robert C. Ness, Karen Rubinstein, Philip D. Kanof	464
20	Adenosine 3‘:5‘-monophosphate receptor proteins in mammalian brain. 1978 ·Journal of Biological Chemistry ·Ulrich Walter, Philip D. Kanof, Howard Schulman, Paul Greengard	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact